Results 191 to 200 of about 23,565 (226)

PKM2 preconditioning protects endothelial cells from pyroptosis and BBB disruption via NRF2/TRX/TXNIP signaling in neonatal hypoxic-ischemic brain injury. [PDF]

J Neuroinflammation
Hu Y, Yu G, Lu L, Nan Y, Wang X, Feng Y, Zhu J, Wang X, Lin Z.   +8 more
europepmc   +1 more source

SLC13A2-transported citrate remodels transcriptional regulation through protein acetylation to suppress tumor growth. [PDF]

Sci Adv
Qin M, Shang L, Chen H, Shi L, Liu C, Ding M, He D, Shao C, Yuan S, Yu H, Hao H, Ma Y, Xiong J.   +12 more
europepmc   +1 more source

GIPC2 regulation of the PKM2/SREBP1 signaling axis controls adipogenic differentiation of mesenchymal stem cells. [PDF]

Cell Death Dis
Wang J, Xin C, Sun Z, Zhao M, Zan Y, Lv Z, Zhu S, Liu J, Wang L.   +8 more
europepmc   +1 more source

The moonlighting functions of glycolytic enzymes in tumorigenesis. [PDF]

Cell Oncol (Dordr)
Chen X, Yang J, Ma Y.
europepmc   +1 more source

Electroacupuncture and Moxibustion Regulate Aerobic Glycolysis and Alleviate Tumor Progression in Mice with Hepatocellular Carcinoma. [PDF]

J Hepatocell Carcinoma
Zhong R, Wu H, Zhu L, Zhang X, Chen Y, Qi Q, Li G, Wang Z, Huang Y, Deng Z, Shi Y, Li J, Wu L.   +12 more
europepmc   +1 more source

The biology of PKM2 in the metabolism and senescence in diabetic kidney disease. [PDF]

J Diabetes Investig
Kayes MI, Kanasaki K.
europepmc   +1 more source

Immunometabolic reprogramming in sepsis: mechanisms, clinical endotypes, and therapeutic opportunities. [PDF]

Front Immunol
Liu C, Cai Y, Ma Q, Sun W.
europepmc   +1 more source

YOD1 mediates isoproterenol-induced cardiac remodeling by deubiquitinating PKM2 and reducing PKM2 tetramerization in cardiomyocytes

Acta Pharmacologica Sinica
Zheng, Qing-song, Xiong, Yong-qiang, Xu, Jia-chen, Qian, Jin-fu, Luo, Wu, Wang, Qin-yan, Zhao, Yan-ni, Luo, Yue, Cui, Ya-qian, Fang, Yi, Guo, Xiao-chen, Chen, Ding-dao, Wang, Yi, Liang, Guang   +13 more
openaire   +1 more source

Circular RNA hsa-circ-0001030 suppresses proliferation and cisplatin tolerance in TSCC via interaction with PKM2. [PDF]

Cancer Drug Resist
Yang H, Yan Y, Tan Z, Xu X, Chen K, Li Q, Liufu N, Ji F.   +7 more
europepmc   +1 more source